Hypofractionated squamous lung cancer is generally moderately sensitive to chemotherapy, and patients with effective treatment will generally experience shrinkage of lung cancer foci, and the clinical symptoms of patients will be significantly reduced. Lung squamous carcinoma belongs to a type of non-small cell lung cancer, and its occurrence has a great relationship with long-term smoking. Radical surgery is the main treatment method for early stage patients, while patients in middle and late stages need to use chemotherapy, radiotherapy, immunotherapy and other anti-tumor treatments in addition to surgery. Most of the hypofractionated squamous lung cancer is moderately sensitive to chemotherapy, and there are differences in sensitivity to chemotherapy among different squamous lung cancer patients, so there are also differences in efficacy after treatment of patients. For diagnosed hypofractionated squamous lung cancer patients, it is generally recommended to consult hospitals, and professional doctors will give the formulation of treatment plans combined with different conditions of patients.